CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Fresenius Q3/26 adjusted core net income rises 15% to €403 million

By Public Technologies
  • Fresenius Q3/26 adjusted core EPS rose 15% year over year to EUR 0.72.
  • Revenue before special items climbed 6% to EUR 5.8 billion; EBIT margin before special items widened to 11%.
  • An exclusive development agreement with WuXi Biologics provides access to up to 37 potential first-to-market biosimilar candidates.
  • The group raised its FY26 EBIT margin indication before special items to above 11.5%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2427898_en) on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk